REQUEST A DEMO
Total
USD $0.00
Search more companies

Ucipharma S.A. (Colombia)

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Ucipharma S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ucipharma S.A. is based in Colombia, with the head office in Bogota D.C.. The enterprise currently operates in the Machinery, Equipment, and Supplies Merchant Wholesalers sector. The company was established on April 13, 2000. 46 (2024) employees currently work for Ucipharma S.A.. In its most recent financial highlights, the company reported a net sales revenue increase of 37.84% in 2023. During that time, Ucipharma S.A.’s total assets decreased by 3.52%. The net profit margin of Ucipharma S.A. decreased by 0.61% in 2023.

Headquarters
Carrera 7 99 53 Torre 2 Piso 19
Bogota D.C.; Bogota D.C; Postal Code: 0810

Contact Details: Purchase the Ucipharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Ucipharma S.A. report to view the information.
Outstanding Shares:
Purchase the Ucipharma S.A. report to view the information.
Registered Capital:
Purchase the Ucipharma S.A. report to view the information.
Incorporation Date:
April 13, 2000
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ucipharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
37.84%
Total operating revenue
37.52%
Operating profit (EBIT)
23.53%
EBITDA
15.81%
Net Profit (Loss) for the Period
29.37%
Total assets
-3.52%
Total equity
-7.97%
Operating Profit Margin (ROS)
-2.09%
Net Profit Margin
-0.61%
Return on Equity (ROE)
8.8%
Debt to Equity Ratio
-3.44%
Quick Ratio
0.24%
Cash Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?